Annual report pursuant to Section 13 and 15(d)

Note 2 - Acquisitions - Summarized Fair Value of Assets and Liabilities Assumed as of Acquisition Date (Details)

v3.7.0.1
Note 2 - Acquisitions - Summarized Fair Value of Assets and Liabilities Assumed as of Acquisition Date (Details) - USD ($)
$ in Thousands
11 Months Ended 12 Months Ended
Aug. 01, 2016
Jun. 30, 2017
Jun. 30, 2017
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
Goodwill, Purchase Accounting Adjustments       $ 1,809  
Goodwill   $ 579,026 $ 579,026 579,026 430,882 $ 390,638
Payments to Acquire Businesses, Net of Cash Acquired       253,785 91,423 $ 420,102
Fair value contingent consideration   3,300 3,300 3,300 $ 38,500  
Advanced Cell Diagnostics (ACD) [Member]            
Net assets acquired   3,245        
Deferred income taxes, net   (26,018)        
Liabilities   588        
Goodwill, Purchase Accounting Adjustments   10,187 10,200      
Current assets, net of cash   (9,372)        
Current assets, net of cash $ 25,196 15,824 15,824 15,824    
Equipment 2,757 2,757 2,757 2,757    
Other long-term assets 3,812 3,812 3,812 3,812    
Goodwill 133,780 143,967 143,967 143,967    
Total assets acquired   (22,185)        
Total assets acquired 366,745 344,560 344,560 344,560    
Liabilities 3,591 4,179 4,179 4,179    
Deferred income taxes, net 78,761 52,743 52,743 52,743    
Net assets acquired 284,393 287,638 287,638 287,638    
Cash paid, net of cash acquired   845        
Payments to Acquire Businesses, Net of Cash Acquired 246,193   247,000 247,038    
Consideration payable   3,600        
Business Combination, Consideration Transferred, Liabilities Incurred   11,000 3,600    
Fair value contingent consideration   (1,200)        
Fair value contingent consideration 38,200 37,000 37,000 37,000    
Net purchase price   3,245        
Net purchase price 284,393     287,638    
Advanced Cell Diagnostics (ACD) [Member] | Developed Technology Rights [Member]            
Intangible assets   43,000        
Intangible assets 107,000 150,000 150,000 150,000    
Advanced Cell Diagnostics (ACD) [Member] | Trade Names [Member]            
Intangible assets   4,900        
Intangible assets 17,000 21,900 21,900 21,900    
Advanced Cell Diagnostics (ACD) [Member] | Customer Relationships [Member]            
Intangible assets   (70,700)        
Intangible assets 77,000 6,300 6,300 6,300    
Advanced Cell Diagnostics (ACD) [Member] | Noncompete Agreements [Member]            
Intangible assets   (200)        
Intangible assets $ 200